Two Sigma Advisers’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,525
| Closed | -$54K | – | 2792 |
|
|
2022
Q4 | $54K | Buy |
1,525
+663
| +77% | +$23.5K | ﹤0.01% | 2356 |
|
|
2022
Q3 | $195K | Buy |
862
+522
| +154% | +$118K | ﹤0.01% | 2210 |
|
|
2022
Q2 | $64K | Sell |
340
-60
| -15% | -$11.3K | ﹤0.01% | 2452 |
|
|
2022
Q1 | $100K | Sell |
400
-715
| -64% | -$179K | ﹤0.01% | 2505 |
|
|
2021
Q4 | $174K | Sell |
1,115
-2,576
| -70% | -$402K | ﹤0.01% | 2316 |
|
|
2021
Q3 | $740K | Sell |
3,691
-2,167
| -37% | -$434K | ﹤0.01% | 1755 |
|
|
2021
Q2 | $1.5M | Sell |
5,858
-5,460
| -48% | -$1.4M | ﹤0.01% | 1443 |
|
|
2021
Q1 | $3.01M | Sell |
11,318
-1,703
| -13% | -$452K | 0.01% | 1074 |
|
|
2020
Q4 | $4.8M | Buy |
13,021
+2,143
| +20% | +$790K | 0.01% | 836 |
|
|
2020
Q3 | $2.66M | Buy |
10,878
+1,990
| +22% | +$486K | 0.01% | 1024 |
|
|
2020
Q2 | $2.56M | Buy |
8,888
+1,337
| +18% | +$385K | 0.01% | 1082 |
|
|
2020
Q1 | $1.54M | Buy |
7,551
+5,163
| +216% | +$1.05M | 0.01% | 1251 |
|
|
2019
Q4 | $1.07M | Buy |
2,388
+1,813
| +315% | +$810K | ﹤0.01% | 1546 |
|
|
2019
Q3 | $177K | Sell |
575
-280
| -33% | -$86.2K | ﹤0.01% | 2064 |
|
|
2019
Q2 | $272K | Buy |
855
+284
| +50% | +$90.3K | ﹤0.01% | 2044 |
|
|
2019
Q1 | $240K | Buy |
+571
| New | +$240K | ﹤0.01% | 2059 |
|
|
2016
Q1 | – | Sell |
-215
| Closed | -$142K | – | 2163 |
|
|
2015
Q4 | $142K | Sell |
215
-11
| -5% | -$7.27K | ﹤0.01% | 1734 |
|
|
2015
Q3 | $109K | Sell |
226
-97
| -30% | -$46.8K | ﹤0.01% | 1714 |
|
|
2015
Q2 | $183K | Buy |
323
+295
| +1,054% | +$167K | ﹤0.01% | 1760 |
|
|
2015
Q1 | $237K | Buy |
+28
| New | +$237K | ﹤0.01% | 1678 |
|